Literature DB >> 30210611

Overexpression of microRNA-936 suppresses non-small cell lung cancer cell proliferation and invasion via targeting E2F2.

Xiao Zhou1, Hui Tao1.   

Abstract

MicroRNA (miR)-936 has been reported to inhibit the cell cycle and glioma cell proliferation. However, the roles of miR-936 in other human tumors remain largely unknown. In the present study, it was indicated that miR-936 was significantly downregulated in non-small cell lung cancer (NSCLC) tissues compared with adjacent normal tissues by reverse transcription-quantitative polymerase chain reaction (RT-qPCR). Results also indicated that miR-936 was downregulated in NSCLC cell lines compared with 16HBE cells. Furthermore, it was demonstrated that overexpression of miR-936 significantly inhibited the proliferation, cell cycle progression and invasion of NSCLC cells. Notably, E2F2 was identified as a target gene of miR-936 in NSCLC cells. The results indicated that E2F2 was upregulated in NSCLC tissues and cell lines, and its expression was negatively correlated with that of miR-936 in NSCLC tissues. Overexpression of miR-936 significantly reduced the protein expression levels of E2F2 in NSCLC cells. Furthermore, restoration of E2F2 rescued the proliferation and invasion of NSCLC cells transfected with miR-936 mimics. To the best of our knowledge, the present findings demonstrated for the first time that miR-936 suppressed NSCLC progression by directly targeting E2F2.

Entities:  

Keywords:  E2F2; invasion; microRNA-936; non-small cell lung cancer; proliferation

Year:  2018        PMID: 30210611      PMCID: PMC6122560          DOI: 10.3892/etm.2018.6490

Source DB:  PubMed          Journal:  Exp Ther Med        ISSN: 1792-0981            Impact factor:   2.447


  33 in total

1.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method.

Authors:  K J Livak; T D Schmittgen
Journal:  Methods       Date:  2001-12       Impact factor: 3.608

2.  E2F2 induces MCM4, CCNE2 and WHSC1 upregulation in ovarian cancer and predicts poor overall survival.

Authors:  L Xie; T Li; L-H Yang
Journal:  Eur Rev Med Pharmacol Sci       Date:  2017-05       Impact factor: 3.507

3.  Metastatic non-small-cell lung cancer (NSCLC): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.

Authors:  S Peters; A A Adjei; C Gridelli; M Reck; K Kerr; E Felip
Journal:  Ann Oncol       Date:  2012-10       Impact factor: 32.976

4.  MicroRNA-1297 contributes to tumor growth of human breast cancer by targeting PTEN/PI3K/AKT signaling.

Authors:  Chao Liu; Zhikui Liu; Xiao Li; Xiaojiang Tang; Jianjun He; Shaoying Lu
Journal:  Oncol Rep       Date:  2017-08-07       Impact factor: 3.906

5.  A comprehensive study of smoking-specific microRNA alterations in head and neck squamous cell carcinoma.

Authors:  Aswini R Krishnan; Hao Zheng; James G Kwok; Yuanhao Qu; Angela E Zou; Avinaash Korrapati; Pin Xue Li; Joseph A Califano; Melbourne F Hovell; Jessica Wang-Rodriguez; Weg M Ongkeko
Journal:  Oral Oncol       Date:  2017-07-13       Impact factor: 5.337

6.  Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases.

Authors:  Xi Chen; Yi Ba; Lijia Ma; Xing Cai; Yuan Yin; Kehui Wang; Jigang Guo; Yujing Zhang; Jiangning Chen; Xing Guo; Qibin Li; Xiaoying Li; Wenjing Wang; Yan Zhang; Jin Wang; Xueyuan Jiang; Yang Xiang; Chen Xu; Pingping Zheng; Juanbin Zhang; Ruiqiang Li; Hongjie Zhang; Xiaobin Shang; Ting Gong; Guang Ning; Jun Wang; Ke Zen; Junfeng Zhang; Chen-Yu Zhang
Journal:  Cell Res       Date:  2008-10       Impact factor: 25.617

7.  Knockdown of long non-coding RNA XIST inhibits cell viability and invasion by regulating miR-137/PXN axis in non-small cell lung cancer.

Authors:  Huijuan Jiang; Hongzhi Zhang; Xigang Hu; Wenbo Li
Journal:  Int J Biol Macromol       Date:  2018-01-11       Impact factor: 6.953

8.  microRNA-99a is downregulated and promotes proliferation, migration and invasion in non-small cell lung cancer A549 and H1299 cells.

Authors:  Changjin Chen; Ziyi Zhao; Yu Liu; Dezhi Mu
Journal:  Oncol Lett       Date:  2015-01-14       Impact factor: 2.967

9.  Upregulation of microRNA-383 inhibits the proliferation, migration and invasion of colon cancer cells.

Authors:  Ying Cui; Le-Gao Chen; Hai-Bo Yao; Jun Zhang; Ke-Feng Ding
Journal:  Oncol Lett       Date:  2017-11-14       Impact factor: 2.967

10.  miR-99a reveals two novel oncogenic proteins E2F2 and EMR2 and represses stemness in lung cancer.

Authors:  Andrea Feliciano; Yoelsis Garcia-Mayea; Luz Jubierre; Cristina Mir; Manuela Hummel; Josep Castellvi; Javier Hernández-Losa; Rosanna Paciucci; Irene Sansano; Yilin Sun; Santiago Ramón Y Cajal; Hiroshi Kondon; Aroa Soriano; Miguel Segura; Alex Lyakhovich; Matilde E LLeonart
Journal:  Cell Death Dis       Date:  2017-10-26       Impact factor: 8.469

View more
  14 in total

1.  miR-638 represses the stem cell characteristics of breast cancer cells by targeting E2F2.

Authors:  Qiu-Yan Lin; Jia-Qi Wang; Li-Li Wu; Wei-E Zheng; Pei-Rui Chen
Journal:  Breast Cancer       Date:  2019-08-13       Impact factor: 4.239

2.  Circular RNA hsa_circ_0005909 modulates osteosarcoma progression via the miR-936/HMGB1 axis.

Authors:  Shuai Ding; Guangquan Zhang; Yanzheng Gao; Shulian Chen; Chen Cao
Journal:  Cancer Cell Int       Date:  2020-07-13       Impact factor: 5.722

Review 3.  Epitranscriptomics and epiproteomics in cancer drug resistance: therapeutic implications.

Authors:  Huibin Song; Dongcheng Liu; Shaowei Dong; Leli Zeng; Zhuoxun Wu; Pan Zhao; Litu Zhang; Zhe-Sheng Chen; Chang Zou
Journal:  Signal Transduct Target Ther       Date:  2020-09-08

4.  Long Non-Coding RNA Differentiation Antagonizing Nonprotein Coding RNA (DANCR) Promotes Proliferation and Invasion of Pancreatic Cancer by Sponging miR-214-5p to Regulate E2F2 Expression.

Authors:  Zhichao Yao; Qiyu Chen; Zhonglin Ni; Lei Zhou; Yigeng Wang; Yuetao Yang; He Huang
Journal:  Med Sci Monit       Date:  2019-06-19

5.  Transcription factor E2F1 positively regulates interferon regulatory factor 5 expression in non-small cell lung cancer.

Authors:  Dan-Dan Feng; Qian Cao; Dao-Qi Zhang; Xiao-Lu Wu; Cai-Xia Yang; Yu-Fei Chen; Tang Yu; Hai-Xiao Qi; Guo-Ping Zhou
Journal:  Onco Targets Ther       Date:  2019-08-23       Impact factor: 4.147

6.  MicroRNA‑936 inhibits the malignant phenotype of retinoblastoma by directly targeting HDAC9 and deactivating the PI3K/AKT pathway.

Authors:  Lishuai Xu; Weidong Li; Qian Shi; Minfeng Wang; Heng Li; Xiaoli Yang; Junjun Zhang
Journal:  Oncol Rep       Date:  2020-01-09       Impact factor: 4.136

7.  Overexpression of microRNA-129-5p in glioblastoma inhibits cell proliferation, migration, and colony-forming ability by targeting ZFP36L1.

Authors:  Xu Guo; Haozhe Piao; Ye Zhang; Peixin Sun; Bing Yao
Journal:  Bosn J Basic Med Sci       Date:  2020-11-02       Impact factor: 3.363

8.  Expression, Prognosis, and Immune Infiltrates Analyses of E2Fs in Human Brain and CNS Cancer.

Authors:  Pan Liao; Shuzhen Han; Honglan Qu
Journal:  Biomed Res Int       Date:  2020-12-15       Impact factor: 3.411

9.  Triptolide-induced apoptosis in non-small cell lung cancer via a novel miR204-5p/Caveolin-1/Akt-mediated pathway.

Authors:  Brian J Philips; Ajay Kumar; Sarah Burki; John P Ryan; Kentaro Noda; Jonathan D'Cunha
Journal:  Oncotarget       Date:  2020-07-14

10.  MicroRNA-936 targets FGF2 to inhibit epithelial ovarian cancer aggressiveness by deactivating the PI3K/Akt pathway.

Authors:  Cuihong Li; Shunrui Yu; Shanshan Wu; Ying Ni; Zixuan Pan
Journal:  Onco Targets Ther       Date:  2019-07-08       Impact factor: 4.147

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.